REG-Acquisition of Own Shares
Lakefront Biotherapeutics repurchased 103,970 ordinary shares between August 3 and August 7, 2026, as part of its ongoing buyback program. The transactions totaled approximately €2.41 million, with shares acquired at an average price of €23.18.
Key figures
- Average price eur
- 23.18
- Shares repurchased
- 103970
- Treasury shares held
- 808186
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.